Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

RXi Pharmaceuticals Corp RXII

"RXi Pharmaceuticals Corp is a clinical-stage RNAi company developing therapeutics based on its proprietary self-delivering RNAi platform and Samcyprone, a topical immunomodulator, which address significant unmet medical needs."


NDAQ:RXII - Post by User

Post by stargazer1on Jul 10, 2018 11:36pm
81 Views
Post# 28297556

Price shooting upward on high volume

Price shooting upward on high volumeThe stock price leveled out the last few days, and today, on a volume of over a million shares it basically went ballistic, going from $1.84 to $2.25. Possibly a press release in the works? Or not. But still, might be a good idea to buy a few shares here. I'm going to buy the warrants. Warrents allow you to buy one share at $9 through 12/16/2021. They do have a low volume transaction. Last trade at 0.51.
<< Previous
Bullboard Posts
Next >>